Latent Expands AI Platform to Unlock Access to a New Generation of Medicines

Clinical-AI innovation company Latent recently announced that its groundbreaking enterprise pharmacy intelligence platform is now officially live in 60 different United States health systems, which together are responsible for approximately 70 million patients. Some of the notable new customers now using the company's platform include Cleveland Clinic, AdventHealth, Cincinnati Children's, Keck Medicine of USC, UNC Health, UnityPoint Health, and WVU Medicine. Latent also unveiled a variety of new autonomous clinical agents designed to improve and streamline patients' access to GLP-1s, as well as new cutting-edge immunology, rheumatology, and cardiology specialty therapies.

Latent Co-Founder Sri Somasundaram expressed the significance of this announcement in the company's press release, sharing that "Advancements in medicine are outpacing the infrastructure built to get new therapies to patients. A treatment can exist, work, and still never reach the person who needs it because access is mired by complex coverage rules. [Latent is] giving health systems the ability to extend the capacity of their pharmacy teams and get patients into the right treatment, without an unnecessary wait."

Founded in 2022 by Sri Somasundaram and Rishabh Jain, Latent has already built a strong reputation for itself as a leader in the medical technology industry with its groundbreaking AI platform built to accelerate and simplify patients' ability to receive life-saving medications and therapies. The company is on track to process over 5.8 million patient medication journeys over the next year - a clear demonstration of Latent's ongoing commitment to improve access, experience, and outcomes for patient care across the country. For more information on this story, view the company's press release below.

See related materials:

• Latent press release
• Latent website
• Latent LinkedIn